Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase NA 11Phase 1/2 6Phase 3 5Phase 1 3Phase 4 1Phase 2/3 1

Status

Completed 7Unknown 5Not yet recruiting 3Terminated 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5

Conditions

Breast Neoplasms 145Carcinoma, Non-Small-Cell Lung 97Colorectal Neoplasms 96Carcinoma, Hepatocellular 69Stomach Neoplasms 65Rectal Neoplasms 54Neoplasms 53Lung Neoplasms 44Prostatic Neoplasms 41Colonic Neoplasms 41Leukemia, Myeloid, Acute 40Nasopharyngeal Carcinoma 39Lymphoma, Large B-Cell, Diffuse 39Uterine Cervical Neoplasms 37Esophageal Neoplasms 33Ovarian Neoplasms 32Neoplasm Metastasis 32Multiple Myeloma 31Lymphoma 31Lymphoma, Follicular 30Leukemia 28Pancreatic Neoplasms 27Recurrence 23Head and Neck Neoplasms 22Brain Neoplasms 21Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 19Lymphoma, Mantle-Cell 18Squamous Cell Carcinoma of Head and Neck 17

Interventions

nimotuzumab 2Cisplatin 2spartalizumab 1sintilimab 1camrelizumab 1Radiotherapy, Intensity-Modulated 1Gemcitabine 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Nasopharyngeal Neoplasms × Clear all
NCT03427827 2024-04-09

DIPPER

Sun Yat-sen University

Phase 3 Unknown
450 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT03700476 2023-03-28

CONTINUUM

Sun Yat-sen University

Phase 3 Unknown
425 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Unknown
384 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT01074021 2015-10-30

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 3 Unknown
480 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT00022373 2014-10-15

Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡